Your shopping cart is currently empty

Osutidine is a selective histamine H2 receptor antagonist that effectively inhibits histamine-stimulated gastric acid secretion. It does not affect the accumulation of [¹⁴C] amino[xylen] bipyridine induced by carbachol or dibutyryl cyclic adenosine monophosphate. Osutidine exhibits irreversible inhibition, including non-competitive inhibition, and is utilized in the study of gastric mucosal injury.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | Osutidine is a selective histamine H2 receptor antagonist that effectively inhibits histamine-stimulated gastric acid secretion. It does not affect the accumulation of [¹⁴C] amino[xylen] bipyridine induced by carbachol or dibutyryl cyclic adenosine monophosphate. Osutidine exhibits irreversible inhibition, including non-competitive inhibition, and is utilized in the study of gastric mucosal injury. |
| In vitro | Osutidine (T-593) inhibits the accumulation of [¹⁴C]AP in isolated canine gastric mucosal cells stimulated by 10⁻⁴ M histamine in a concentration-dependent manner. Its IC₅₀ value is 1.85 × 10⁻⁶ M. For the accumulation of [¹⁴C]AP stimulated by 10⁻⁴ M dbcAMP in the same cells, Osutidine shows only a slight inhibitory effect, with a maximum inhibition rate of 20-32%. |
| In vivo | Osutidine (T-593), administered as a single intraperitoneal injection at doses ranging from 6 to 60 mg/kg, offers significant protective effects on the gastric mucosa of Sprague-Dawley rats and markedly inhibits ethanol-induced gastric mucosal damage in a dose-dependent manner. |
| Molecular Weight | 456.58 |
| Formula | C19H28N4O5S2 |
| Cas No. | 140695-21-2 |
| Smiles | C(SCCN/C(/NCC(O)C1=CC=C(O)C=C1)=N/S(C)(=O)=O)C=2OC(CNC)=CC2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.